Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|November 16, 2019
The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participantsMaulik Patel, Joseph Chen, Stephanie McGrory, et al.
Clinical Pharmacokinetics|May 3, 2021
The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy ParticipantsJerry Li, Yazdi K Pithavala, Jason Gong, et al.
Clinical Pharmacokinetics|May 17, 2013
Clinical pharmacology of axitinibYing Chen, Michael A Tortorici, May Garrett, et al.
Clinical Pharmacology in Drug Development|July 21, 2021
Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy ParticipantsHuiping Xu, Melissa T O'Gorman, Sunil Nepal, et al.
Cancer Chemotherapy and Pharmacology|January 16, 2015
Effect of axitinib on the QT interval in healthy volunteersAna Ruiz-Garcia, Brett E Houk, Yazdi K Pithavala, et al.
Clinical Pharmacokinetics|May 3, 2021
Pharmacokinetics of Lorlatinib After Single and Multiple Dosing in Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer: Results from a Global Phase I/II StudyJoseph Chen, Melissa T O'Gorman, Lee P James, et al.
Investigational New Drugs|June 15, 2011
Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancerJean-Philippe Spano, Malcolm J Moore, Yazdi K Pithavala, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2016
Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancerMay Garrett, Timothy Taylor, Diane R Mould, et al.
Investigational New Drugs|February 10, 2015
Axitinib plasma pharmacokinetics and ethnic differencesYing Chen, Akiyuki Suzuki, Michael A Tortorici, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 13, 2026
AI-Powered Lesion-Level Tumor Growth Inhibition Modeling Improves Model Stability and Prognostic Association With PFSAlan Liu, Chong Duan, Kevin Maresca, et al.
Pageof 4